|
BioPharm International's Virus Inactivation Series: A Preface
|
|
|
by William N. Drohan, Clearant Inc. and Shirley I. Miekka
|
|
|
|
Inactivation of Viruses: An Introduction to the Series
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 1: Skin, Bone, and Cells
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 2: Red Blood Cells and Platelets
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 3a: Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 3b: Plasma and Plasma Products (Treatments Other than Heat or Solvent/Detergent)
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 4: Culture Media, Biotechnology Products, and Vaccines
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 5: Disinfection
|
|
|
by Gail Sofer, BioReliance
|
|
|
|
Part 6: Inactivation Methods Grouped by Virus
|
|
|
by Gail Sofer, BioReliance, Dorothy C. Lister, and Jeri Ann Boose
|
|
|
